Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank46
3Y CAGR-6.6%
5Y CAGR+17.4%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-6.6%/yr
Annual compound
5Y CAGR
+17.4%/yr
Recent deceleration
Percentile
P46
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.00-97.0%
20240.16+7056.3%
20230.00-61.9%
20220.01-54.5%
20210.01+500.9%
20200.00-73.2%
20190.01-
20180.00-
20170.00-
20160.00-